8-K 1 f34959e8vk.htm FORM 8-K e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 30, 2007
GENOMIC HEALTH, INC.
(Exact name of registrant as specified in its charter)
         
Delaware   000-51541   77-0552594
(State or Other Jurisdiction of        
Incorporation)   (Commission File Number)   (I.R.S. Employer
Identification No.)
     
301 Penobscot Drive    
Redwood City, California   94063
(Address of principal executive offices)   (Zip Code)
(650) 556-9300
(Registrant’s telephone number,
including area code)
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))
 
 

 

TABLE OF CONTENTS

Item 2.02 Results of Operations and Financial Condition
Item 9.01 Financial Statements and Exhibits
SIGNATURE
EXHIBIT INDEX
EXHIBIT 99.1

Table of Contents

Item 2.02 Results of Operations and Financial Condition.
     On October 30, 2007, Genomic Health, Inc. issued a press release announcing financial results for its third fiscal quarter ended September 30, 2007. The full text of the press release is furnished as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
     (d) Exhibits
  99.1    Press release issued by Genomic Health, Inc. dated October 30, 2007.

2

Table of Contents

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     Dated: October 30, 2007
             
    GENOMIC HEALTH, INC.    
 
            
 
  By:   /s/ G. Bradley Cole     
         
 
      G. Bradley Cole
    
 
      Executive Vice President and Chief Financial Officer    

3

Table of Contents

GENOMIC HEALTH, INC.
EXHIBIT INDEX
     
Exhibit    
Number   Description
99.1
  Press release issued by Genomic Health, Inc. dated October 30, 2007

4